Protein-losing enteropathy in paracoccidioidomycosis identified by scintigraphy: report of three cases

Aline Dayara de Mendonça Berni; Erivaldo Elias Júnior; Adalberto Arão Filho; Anamaria Mello Miranda Paniago

Protein-losing enteropathy in paracoccidioidomycosis identified by scintigraphy: report of three cases

Braz J Infect Dis. 2010 Sep-Oct;14(5):540-3.

Authors

Aline Dayara de Mendonça Berni¹, Erivaldo Elias Júnior, Adalberto Arão Filho, Anamaria Mello Miranda Paniago

Affiliation

¹ Faculdade de Medicina, Universidade Federal do Mato Grosso do Sul, Campo Grande, MS.

PMID: 21221488

Abstract

Paracoccidioidomycosis (PCM) or South American Blastomycosis is a systemic fungal infection caused by a dimorphic fungus, Paracoccidioides brasiliensis. It represents the most important systemic mycosis in South America and with higher prevalence among male inhabitants of the rural area. PCM usually affects the lungs, and rarely the intestines. The authors report three cases of PCM, treated at the University Hospital of Universidade Federal de Mato Grosso do Sul whose scintigraphy with technetium-99 labeled human albumin revead intestinal protein loss.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Anti-Infective Agents / therapeutic use
Humans
Itraconazole / therapeutic use
Male
Paracoccidioides / isolation & purification*
Paracoccidioidomycosis / complications
Paracoccidioidomycosis / diagnostic imaging*
Paracoccidioidomycosis / drug therapy
Protein-Losing Enteropathies / diagnostic imaging*
Protein-Losing Enteropathies / drug therapy
Protein-Losing Enteropathies / microbiology
Radionuclide Imaging
Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

Anti-Infective Agents
Itraconazole
Trimethoprim, Sulfamethoxazole Drug Combination